Avadel Pharmaceuticals (AVDL)
NASDAQ: AVDL
· Real-Time Price · USD
13.69
0.19 (1.41%)
At close: Aug 15, 2025, 3:59 PM
13.64
-0.33%
After-hours: Aug 15, 2025, 07:44 PM EDT
Avadel Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 194.45M | 169.12M | 138.16M | 95.15M | 55.14M | 27.96M | 8.51M | 1.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.09M |
Cost of Revenue | 19.33M | 15.28M | 11.16M | 5.12M | 2.37M | 1.43M | 1.33M | 1.61M | 1.82M | 1.49M | 1.11M | 904K | 856K | 815K | 614K | 417K | 3.5M |
Gross Profit | 175.12M | 153.84M | 127M | 90.03M | 52.77M | 26.53M | 7.18M | -115K | -1.82M | -1.49M | -1.11M | -904K | -856K | -815K | -614K | -417K | 6.59M |
Operating Income | -19.37M | -42.4M | -64M | -98.79M | -135.59M | -137.85M | -135.99M | -117.84M | -98.23M | -98.56M | -98.66M | -107.36M | -99.36M | -85.55M | -76.67M | -64.7M | -2.5M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -26.67M | -49.08M | -73M | -106.65M | -156.66M | -160.78M | -159.26M | -143.15M | -112.06M | -111.44M | -110.72M | -117.75M | -107.84M | -93.14M | -80.63M | -70.27M | -10.76M |
Net Income | -26.41M | -48.83M | -72.58M | -106.22M | -156.83M | -160.28M | -158.94M | -142.81M | -141.82M | -137.46M | -132.31M | -134.17M | -90.31M | -77.33M | -66.31M | -56.01M | -5.55M |
Selling & General & Admin | 178M | 181.04M | 177.72M | 176.49M | 175.86M | 151.71M | 127.39M | 102.32M | 77.35M | 74.52M | 78.56M | 85.75M | 79.12M | 68.5M | 56.44M | 43.58M | 35.5M |
Research & Development | 16.48M | 15.2M | 13.28M | 12.33M | 12.5M | 13.26M | 17.14M | 17.22M | 17.54M | 20.7M | 16.57M | 18.02M | 20.24M | 17.1M | 20.28M | 21.47M | 18.76M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -247K | -247K | -247K | -214K | 84K | 84K | 172K | 217K | 166K | 166K | 78K |
Operating Expenses | 194.48M | 196.24M | 191M | 188.81M | 188.36M | 164.97M | 144.52M | 119.54M | 94.89M | 95.22M | 95.14M | 103.77M | 99.36M | 85.6M | 76.72M | 65.05M | 54.47M |
Interest Expense | 6M | 10.83M | 10.48M | 9.64M | 9.22M | 9.89M | 10.79M | 12.37M | 13.58M | 12.34M | 13.24M | 11.61M | 10.03M | 9.94M | 9.1M | 10.43M | 11.73M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.46M | -14.46M | -14.46M |
Cost & Expenses | 213.82M | 211.52M | 202.16M | 193.94M | 190.73M | 165.81M | 144.68M | 119.58M | 94.89M | 95.22M | 95.14M | 103.77M | 99.36M | 85.6M | 76.72M | 65.05M | 57.76M |
Income Tax Expense | -263K | -248K | -428K | -427K | 172K | -501K | -316K | -335K | 29.77M | 26.02M | 21.6M | 16.43M | -17.53M | -15.82M | -14.32M | -14.26M | -5.21M |
Shares Outstanding (Basic) | 96.6M | 96.39M | 96.3M | 96.15M | 91.69M | 95.02M | 89.38M | 77.25M | 63.89M | 63.23M | 60.2M | 59.04M | 58.72M | 58.62M | 57.9M | 58.49M | 58.44M |
Shares Outstanding (Diluted) | 96.6M | 96.39M | 96.3M | 96.15M | 91.69M | 95.02M | 89.38M | 77.25M | 63.89M | 63.23M | 60.2M | 59.04M | 58.82M | 58.62M | 58.59M | 58.49M | 58.44M |
EPS (Basic) | -0.27 | -0.52 | -0.77 | -1.15 | -1.84 | -2.02 | -2.15 | -2.07 | -2.31 | -2.28 | -2.23 | -2.28 | -1.54 | -1.32 | -1.13 | -0.95 | -0.05 |
EPS (Diluted) | -0.27 | -0.52 | -0.77 | -1.15 | -1.84 | -2.02 | -2.15 | -2.07 | -2.31 | -2.28 | -2.23 | -2.28 | -1.54 | -1.32 | -1.13 | -0.95 | -0.13 |
EBITDA | -14.45M | -35.57M | -60.51M | -95.44M | -145.71M | -149.11M | -146.1M | -128.6M | -96.65M | -97.6M | -96.37M | -105.23M | -96.95M | -82.39M | -70.53M | -58.71M | -41.53M |
EBIT | -13.59M | -38.25M | -62.52M | -97.01M | -147.44M | -150.89M | -148.47M | -130.77M | -98.47M | -99.1M | -97.48M | -106.14M | -97.81M | -83.2M | -71.53M | -59.84M | 974K |
Depreciation & Amortization | 2.14M | 2.68M | 2M | 1.55M | 1.72M | 1.77M | 2.37M | 2.18M | 1.82M | 1.49M | 1.11M | 904K | 856K | 815K | 1.01M | 1.13M | 1.45M |